Vitamin D deficiency and cardiovascular disease: Is there a role for vitamin D therapy in heart failure?

Current Opinion in Investigational Drugs

Volumn 11, Issue 3, 2010, Pages 309-314

  Lee, W ^a   Kang, P M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cardiac hypertrophy; Chronic kidney disease; Congestive heart failure; Vitamin D; Vitamin D deficiency

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCITRIOL; COLECALCIFEROL; DOXERCALCIFEROL; ERGOCALCIFEROL; PARICALCITOL; VITAMIN D;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; NONHUMAN; REVIEW; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

ANIMALS; CARDIOVASCULAR DISEASES; HEART FAILURE; HUMANS; KIDNEY FAILURE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77649156828     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol (2005) 289(1):F8-F28.
2. Holick MF: Vitamin D deficiency. N Engl J Med (2007) 357(3): 266-281.
3. Demay MB: Mechanism of vitamin D receptor action. Ann N Y Acad Sci (2006) 1068:204-213.
4. Norman AW: Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology (2006) 147(12):5542-5548.
5. Chen S, Glenn DJ, Ni W, Grigsby CL, Olsen K, Nishimoto M, Law CS, Gardner DG: Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension (2008) 52(6):1106-1112.
6. Simpson RU, Thomas GA, Arnold AJ: Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem (1985) 260(15):8882-8891.
7. Weishaar RE, Simpson RU: Vitamin D3 and cardiovascular function in rats. J Clin Invest (1987) 79(6):1706-1712.
8. Norman AW, Mizwicki MT, Norman DP: Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov (2004) 3(1):27-41.
9. Stechschulte SA, Kirsner RS, Federman DG: Vitamin D: Bone and beyond, rationale and recommendations for supplementation. Am J Med (2009) 122(9):793-802.
10. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and ? cell dysfunction. Am J Clin Nutr (2004) 79(5):820-825.
11. Norman AW, Frankel JB, Heldt AM, Grodsky GM: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 209(4458):823-825.
12. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 72(3):690-693.
13. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 32(5 Suppl 3):S112-S119.
14. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol (2004) 24(5):503-510.
15. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol (1995) 5(12): 2024-2031.
16. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant (1996) 11(7):1277-1285.
17. Foley RN: Clinical epidemiology of cardiac disease in dialysis patients: Left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial (2003) 16(2):111-117.
18. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P: Low vitamin D status: A contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol (2003) 41(1):105-112.
19. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis (1999) 33(1):73-81.
20. Burgess ED, Hawkins RG, Watanabe M: Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens (1990) 3(12 Pt 1):903-905.
21. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 349(5): 446-456. (Pubitemid 36910023)
22. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CAJr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol (2005) 16(4):1115-1125.
23. 2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest (1996) 97(7): 1577-1588.
24. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU: 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol (1997) 272 (4 Pt 2):H1751-1758.
25. O'Connell TD, Weishaar RE, Simpson RU: Regulation of myosin isozyme expression by vitamin D3 deficiency and 1,25-dihydroxyvitamin D3 in the rat heart. Endocrinology (1994) 134(2):899-905.
26. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC: Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab (2005) 288(1):E125-E132.
27. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 110:229-238.
28. 2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol (2007) 103(3-5):533-537.
29. Chen S, Wu J, Hsieh JC, Whitfield GK, Jurutka PW, Haussler MR, Gardner DG: Suppression of ANP gene transcription by liganded vitamin D receptor: Involvement of specific receptor domains. Hypertension (1998) 31(6):1338-1342.
30. Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, Rigor DL, Stillman I, Tamez H, Kroeger PE, Wu-Wong RR et al: Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA (2007) 104(43):16810-16815.
31. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 117(4):503-511.
32. Doherty TM, Tang W, Dascalos S, Watson KE, Demer LL, Shavelle RM, Detrano RC: Ethnic origin and serum levels of 1α,25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation (1997) 96(5):1477-1481.
33. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation (1997) 96(6):1755-1760.
34. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E: Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract (1995) 27(3):181-188.
35. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab (2009) 94(10):4023-4030.
36. Kristal-Boneh E, Froom P, Harari G, Ribak J: Association of calcitriol and blood pressure in normotensive men. Hypertension (1997) 30(5):1289-1294.
37. Witham MD, Nadir MA, Struthers AD: Effect of vitamin D on blood pressure: A systematic review and meta-analysis. J Hypertens (2009) 27(10):1948-1954.
38. Brown J, Nunez S, Russell M, Spurney C: Hypocalcemic rickets and dilated cardiomyopathy: Case reports and review of literature. Pediatr Cardiol (2009) 30(6):818-823.
39. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ: Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol (2008) 102(11):1540-1544.
40. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol (2008) 52(24): 1949-1956.
41. Kang PM, Izumo S: Apoptosis and heart failure: A critical review of the literature. Circ Res (2000) 86(11):1107-1113. (Pubitemid 30396034)
42. Kang PM, Izumo S: Apoptosis in heart: Basic mechanisms and implications in cardiovascular diseases. Trends Mol Med (2003) 9(4):177-182.
43. Sauer B, Ruwisch L, Kleuser B: Antiapoptotic action of 1α,25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res (2003) 13(4):339-347.
44. Riachy R, Vandewalle B, Kerr Conte J, Moerman E, Sacchetti P, Lukowiak B, Gmyr V, Bouckenooghe T, Dubois M, Pattou F: 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: Implication of the antiapoptotic protein A20. Endocrinology (2002) 143(12): 4809-4819.
45. 2 vitamin D3 -induced anti-apoptotic PI3K/AKT signaling in osteoblasts. J Bone Miner Res (2008) 23(8):1238-1248.
46. Xiang G, Seki T, Schuster MD, Witkowski P, Boyle AJ, See F, Martens TP, Kocher A, Sondermeijer H, Krum H, Itescu S: Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem (2005) 280(47):39394-39402.
47. Wang Y, De Keulenaer GW, Lee RT: Vitamin D3-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem (2002) 277(29):26496-26500.
48. Papagianni A, Dovas S, Bantis C, Belechri AM, Kalovoulos M, Dimitriadis C, Efstratiadis G, Alexopoulos E, Memmos D: Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. Am J Nephrol (2008) 28(2):265-274.
49. Seyrek N, Karayaylali I, Balal M, Paydas S, Aikimbaev K, Cetiner S, Seydaoglu G: Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients? Scand J Urol Nephrol (2005) 39(5): 405-409.
50. Simpson RU, Hershey SH, Nibbelink KA: Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol (2007) 103(3-5): 521-524.
51. Li Y, Spataro BC, Yang J, Dai C, Liu Y: 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int (2005) 68(4):1500-1510.